SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018759
Filing Date
2024-05-30
Accepted
2024-05-30 17:16:27
Documents
16
Period of Report
2024-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240528_8k.htm   iXBRL 8-K 53042
2 EXHIBIT 3.1 ex_680309.htm EX-3.1 8777
3 EXHIBIT 10.1 ex_680310.htm EX-10.1 66515
  Complete submission text file 0001437749-24-018759.txt   303990

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240529.xsd EX-101.SCH 3943
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240529_def.xml EX-101.DEF 13901
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240529_lab.xml EX-101.LAB 18364
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240529_pre.xml EX-101.PRE 13933
19 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240528_8k_htm.xml XML 5064
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241006612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)